Sino-American antibody company Adagene (Nasdaq: ADAG) has announced a strategic investment and option exercise by Sanofi ...

Vertex Pharmaceuticals today announced that the European Commission has granted approval for Alyftrek ...

Mental health company atai Life Sciences (NASDAQ: ATAI) was trading more than 31% higher during Tuesday morning’s trading in ...

The US Food and Drug Administration (FDA) has issued a complete response letter (CRL) for Unicycive Therapeutics’ New Drug ...

Marking a new step forward in its international growth, Spanish privately-held pharma company Esteve has entered into an ...

A Republican-backed amendment to the sweeping budget proposal championed by US president Donald Trump would sharply reduce ...

Shares in US biotech INmune Bio slumped by around 60% following news that its Phase II Alzheimer’s study failed to hit its ...

Denmark-based Vesper Bio, a biotech developing an oral therapy for frontotemporal dementia, has announced the appointment of ...

Clinical-stage oncology company Revolution Medicines and fellow USA-based Summit Therapeutics have entered into a clinical ...

Systemic sclerosis is an autoimmune connective tissue disease that causes debilitating fibrosis of the skin and internal ...

Swedish biotech Camurus (Nasdaq Stockholm: CAMX) has secured EU marketing authorization for its once-monthly acromegaly ...

Despite major strides in antiretroviral therapy (ART), the human immunodeficiency virus (HIV) market still faces serious ...